These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 29950810)

  • 21. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
    Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linezolid: an oxazolidinone antimicrobial agent.
    Paladino JA
    Am J Health Syst Pharm; 2002 Dec; 59(24):2413-25. PubMed ID: 12503340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to linezolid caused by modifications at its binding site on the ribosome.
    Long KS; Vester B
    Antimicrob Agents Chemother; 2012 Feb; 56(2):603-12. PubMed ID: 22143525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linezolid, the first oxazolidinone antibacterial agent.
    Leach KL; Brickner SJ; Noe MC; Miller PF
    Ann N Y Acad Sci; 2011 Mar; 1222():49-54. PubMed ID: 21434942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Linezolid: antibacterial activity, clinical efficacy and resistance].
    Bourgeois-Nicolaos N; Piriou O; Butel MJ; Doucet-Populaire F
    Ann Biol Clin (Paris); 2006; 64(6):549-64. PubMed ID: 17162258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.
    Toh SM; Xiong L; Arias CA; Villegas MV; Lolans K; Quinn J; Mankin AS
    Mol Microbiol; 2007 Jun; 64(6):1506-14. PubMed ID: 17555436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxazolidinone antibiotics.
    Diekema DJ; Jones RN
    Lancet; 2001 Dec; 358(9297):1975-82. PubMed ID: 11747939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proper use of antibiotics: situation of linezolid at the intensive care unit of the Tunisian Military Hospital.
    Safa L; Afif N; Zied H; Mehdi D; Ali YM
    Pan Afr Med J; 2016; 25():196. PubMed ID: 28270901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant
    Lee BJ; Vu BN; Seddon AN; Hodgson HA; Wang SK
    Ann Pharmacother; 2020 Dec; 54(12):1243-1251. PubMed ID: 32506921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid resistance genes and genetic elements enhancing their dissemination in enterococci and streptococci.
    Sadowy E
    Plasmid; 2018 Sep; 99():89-98. PubMed ID: 30253132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.
    Falagas ME; Vardakas KZ
    Drug Saf; 2008; 31(9):753-68. PubMed ID: 18707190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumonia.
    Burkhardt O; Pletz MW; Mertgen CP; Welte T
    Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):123-30. PubMed ID: 18221168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to linezolid in Staphylococcus spp. clinical isolates associated with ribosomal binding site modifications: novel mutation in domain V of 23S rRNA.
    Musumeci R; Calaresu E; Gerosa J; Oggioni D; Bramati S; Morelli P; Mura I; Piana A; Are BM; Cocuzza CE
    New Microbiol; 2016 Oct; 39(4):269-273. PubMed ID: 27727405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antimicrobial and clinical effect of linezolid (ZYVOX), new class of synthetic antibacterial drug].
    Irinoda K; Nomura S; Hashimoto M
    Nihon Yakurigaku Zasshi; 2002 Oct; 120(4):245-52. PubMed ID: 12425150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of Linezolid Resistance Among Clinical
    Ruiz-Ripa L; Feßler AT; Hanke D; Eichhorn I; Azcona-Gutiérrez JM; Alonso CA; Pérez-Moreno MO; Aspiroz C; Bellés A; Schwarz S; Torres C
    Microb Drug Resist; 2021 Feb; 27(2):145-153. PubMed ID: 32456543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
    Rybak JM; Marx K; Martin CA
    Pharmacotherapy; 2014 Nov; 34(11):1198-208. PubMed ID: 25266820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LRE-Finder, a Web tool for detection of the 23S rRNA mutations and the optrA, cfr, cfr(B) and poxtA genes encoding linezolid resistance in enterococci from whole-genome sequences.
    Hasman H; Clausen PTLC; Kaya H; Hansen F; Knudsen JD; Wang M; Holzknecht BJ; Samulioniené J; Røder BL; Frimodt-Møller N; Lund O; Hammerum AM
    J Antimicrob Chemother; 2019 Jun; 74(6):1473-1476. PubMed ID: 30863844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linezolid--a review of the first oxazolidinone.
    Norrby R
    Expert Opin Pharmacother; 2001 Feb; 2(2):293-302. PubMed ID: 11336587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.